Katie Fanning is the founder of Mozart Therapeutics. Mozart Therapeutics has raised $80M in total funding. Latest round: Series A. Based in Seattle, WA.
Katie Fanning is the President and CEO of Mozart Therapeutics, a biotech startup developing disease-modifying therapies for autoimmune and inflammatory diseases. She has led the company through its founding in 2020 and secured over $80 million in total funding.
Full founder directory · Investor directory · Company funding database · Fundraising library